Results 301 to 310 of about 159,279 (352)

Evaluation of a Combined Live Attenuated Vaccine against Lumpy Skin Disease, Contagious Bovine Pleuropneumonia and Rift Valley Fever. [PDF]

Vaccines (Basel)
Bamouh Z, Elarkam A, Elmejdoub S, Hamdi J, Boumart Z, Smith G, Suderman M, Teffera M, Wesonga H, Wilson S, Watts DM, Babiuk S, Pickering B, Elharrak M.   +13 more
europepmc   +1 more source

The aroA and luxS Double-Gene Mutant Strain Has Potential to Be a Live Attenuated Vaccine against Salmonella Typhimurium. [PDF]

Vaccines (Basel)
Zuo W, Yang D, Wu X, Zhang B, Wang X, Hu J, Qi J, Tian M, Bao Y, Wang S.   +9 more
europepmc   +1 more source

CA-CAS-01-A: A Permissive Cell Line for Isolation and Live Attenuated Vaccine Development Against African Swine Fever Virus. [PDF]

J Microbiol
Lee SC, Kim Y, Cha JW, Chathuranga K, Dodantenna N, Kwon HI, Kim MH, Jheong W, Yoon IJ, Lee JY, Yoo SS, Lee JS.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

LIVE ATTENUATED VARICELLA VACCINE

Annual Review of Microbiology, 1996
Varicella-zoster virus (VZV) is a ubiquitous human pathogen that causes varicella, commonly called chicken pox; establishes latency; and reactivates as herpes zoster, referred to as shingles. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
A M, Arvin, A A, Gershon
openaire   +2 more sources

Influenza Vaccination with a Live Attenuated Vaccine

AJN, American Journal of Nursing, 2009
Influenza is a highly contagious, acute respiratory illness with a long history of outbreaks dating back several centuries. Although immunization is an effective means of protection against influenza, vaccination rates have been suboptimal, especially among certain high-risk groups, including children and health care personnel.
Michele, Michael, Elizabeth, Helm, Brigit, Van Graafeiland, Frank, Malinoski, Jay, Bauman   +4 more
openaire   +2 more sources

Live Attenuated Influenza Vaccine

2014
Cold-adapted Ann Arbor based live attenuated influenza vaccine (LAIV) has been available in the USA since 2003. The vaccine is efficacious against influenza infection. Features of LAIV include: easy administration suitable for mass immunization, cross-reactivity to drifted strains for broader coverage, and establishment of herd immunity for control of ...
Hong, Jin, Kanta, Subbarao
openaire   +2 more sources

Live Attenuated Vaccine Vectors

International Journal of Technology Assessment in Health Care, 1994
AbstractSeveral different live attenuated vaccine vectors currently are under development. These vaccines are composed of living viruses or bacteria that are innocuous to the host but can replicate in host tissues and induce immune responses. The genes encoding foreign antigens can be inserted into these vectors to produce multivalent vaccines that ...
openaire   +2 more sources

Live attenuated influenza vaccine

2008
The development of the live, attenuated influenza vaccine (LAIV), based on the cold-adapted (ca), attenuated ca A/Ann Arbor/6/60 and ca B/Ann Arbor/1/66 backbones, has spanned several decades. The vaccine contains three vaccine strains, two attenuated influenza A strains and one attenuated influenza B strain; these vaccine strains are genetic ...
Harry Greenberg, George Kemble
openaire   +1 more source

Live attenuated tetravalent dengue vaccine

Vaccine, 2000
The development of a live attenuated tetravalent dengue vaccine is currently the best strategy to obtain a vaccine against dengue viruses. The Mahidol University group developed candidate live attenuated vaccines by attenuation through serial passages in certified primary cell cultures.
N, Bhamarapravati, Y, Sutee
openaire   +2 more sources